Public M&A: Experience
- Permanent TSB Group Holdings plc on its formal sales process and €1.62 billion recommended offer by BAWAG
- Irish Continental Group plc on its recommended €1.2 billion MBO through Bluefin Bidco
- Barclays Bank, as lead lenders and arrangers, on KKR and EnergyCap’s £5.75 billion recommended offer for DCC plc
- JPMorgan Chase Bank, as Alkermes lender, on Alkermes $2.1 billion acquisition of Avadel plc
- Dalata Hotel Group plc on its formal sales process $1.4 billion acquisition by Pandox AB and Eiendomsspar AS
- K1 Investment Management LLC on its P2P acquisition of MariaDB by way of tender offer
- Endo, Inc. on its $6.7 billion merger with Mallinckrodt plc
- Hibernia REIT plc on its €1.09bn recommended takeover offer from the Brookfield Group
- ICON plc on its $12bn acquisition of PRA Life Sciences, Inc. in a cash and share deal
- UDG Healthcare plc on its £2.6bn recommended takeover offer from Clayton Dubilier & Rice
- Xeris Pharmaceuticals, Inc. on its acquisition of Strongbridge Biopharma plc
- B&J Holdings and the bidco on the proposed €718m recommended takeover of AppleGreen plc
- Henderson Park on its €1.34bn recommended takeover offer for Green REIT plc
- The Stars Group on its merger with Flutter Entertainment Plc (Paddy Power Betfair)
- Abbey plc and its independent directors on an unconditional offer by its majority shareholder
- Morgan Stanley, as AbbVie's lead financial advisor and lender, on AbbVie's $63bn acquisition of Allergan plc
- Sumitomo Corporation on its €751m recommended takeover offer for Fyffes plc
- Verizon Communications on its acquisition of FleetMatics Group for $2.4bn
- Johnson Controls Inc on its $20bn merger with Tyco plc
- Medtronic Inc on its $49bn acquisition of Covidien plc
- Towers Watson plc on its merger with Willis Group
- International Power Plc on the court approved cross-border amalgamation of its Irish, Italian and Hungarian businesses
- Perrigo Company plc on its successful defence of a hostile takeover attempt by Mylan N.V.
- Endo International plc on its acquisition of Par Pharmaceutical Holdings, Inc for $8.05bn
- XL Group on its $4.2bn acquisition of Catlin Group
- Takeda on Irish aspects of its €65.7bn acquisition of Irish headquartered Shire plc